Pharma firm WuXi to create 200 more jobs with investment here
Chinese company WuXi Biologics plans to spend 70pc of its $1bn (€906m) overseas investment in the next three years in Dundalk, chief executive Dr Chris Chen said.
He was speaking in the Co Louth town as he confirmed a planning application for a second facility - WiXu Vaccines - on a site adjacent to WuXi Biologics.
Last year it announced a €325m investment on a Pharma campus in Dundalk with the creation of 400 jobs by 2020 in WiXu Biologics. More than 700 people are currently working on its construction.
WuXi Vaccines, if granted permission, will see a €200m investment creating 200 additional jobs in the next five years.
Please log in or register with Independent.ie for free access to this article.
Dr Chen said the speed of progress in Dundalk had prompted him to tell staff there: "WiXu is known for 'WiXu speed'... I said now I am going to change it to 'Irish speed'.
"I want my China team to know the Irish team is not inferior, it is on par or even better than China," he said.
"Our business is very simple, we want to transform the biotech industry.
"We want to make medicines for people who cannot afford it and for those who can afford it, to make it cheaper."
The investment has the support of the IDA.